| Stromal-initiated changes in the bone promote metastatic niche development X Luo, Y Fu, AJ Loza, B Murali, KM Leahy, MK Ruhland, M Gang, X Su, ... Cell reports 14 (1), 82-92, 2016 | 131 | 2016 |
| Therapy-Induced Senescence Drives Bone Loss Z Yao, B Murali, Q Ren, X Luo, DV Faget, T Cole, B Ricci, D Thotala, ... Cancer Research 80 (5), 1171-1182, 2020 | 101 | 2020 |
| Human ribonuclease H1 resolves R-loops and thereby enables progression of the DNA replication fork S Parajuli, DC Teasley, B Murali, J Jackson, A Vindigni, SA Stewart Journal of Biological Chemistry 292 (37), 15216-15224, 2017 | 77 | 2017 |
| Inhibition of the stromal p38MAPK/MK2 pathway limits breast cancer metastases and chemotherapy-induced bone loss B Murali, Q Ren, X Luo, DV Faget, C Wang, RM Johnson, T Gruosso, ... Cancer research 78 (19), 5618-5630, 2018 | 62 | 2018 |
| Low phosphate alters lateral root setpoint angle and gravitropism H Bai, B Murali, K Barber, C Wolverton American journal of botany 100 (1), 175-182, 2013 | 46 | 2013 |
| p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy DV Faget, X Luo, MJ Inkman, Q Ren, X Su, K Ding, MR Waters, GK Raut, ... Cancer Discovery, OF1-OF24, 2023 | 10 | 2023 |
| Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020 L Durbin, B Murali, S Li, L Zhao, S Hawthorne, G Kanas, C Davis, O Clark Cancer Treatment and Research Communications 29, 100462, 2021 | 10 | 2021 |
| Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019 B Murali, L Durbin, S Vijaykumar, L Yang, S Li, L Zhao, S Hawthorne, ... Breast Cancer Research and Treatment, 2022 | 5 | 2022 |
| Treatment patterns in advanced/metastatic non-small-cell lung cancer in China: results from the CancerMPact® survey 2021 L Durbin, B Murali, S Li, S Hawthorne, O Clark Future Oncology, 2024 | | 2024 |
| Inhibition of stromal p38MAPKalpha triggers innate-adaptive anti-tumor immunity in metastatic breast cancer DV Faget, X Luo, Q Ren, J Ye, T Cole, Z Yao, B Murali, X Su, Y Xu, ... Cancer Research 82 (12_Supplement), 251-251, 2022 | | 2022 |
| Therapy-induced senescence drives bone loss SA Stewart, Z Yao, B Murali, Q Ren, X Luo, DV Faget, T Cole, B Ricci, ... Cancer Research, 2020 | | 2020 |
| Targeting the Microenvironment: Approaches for Reducing Breast Cancer Metastases and Chemotherapy-induced Bone Loss B Murali | | 2018 |
| Inhibition of stromal p38MAPK abrogates breast cancer metastasis SA Stewart, B Murali, Q Ren, X Su, K Flannagan, X Luo, J Sponagel, Y Fu, ... Cancer Research 77 (13 Supplement), 2963-2963, 2017 | | 2017 |
| Human Ribonuclease H1 facilitates replication fork movement S Parajuli, DC Teasley, B Murali, J Jackson, A Vindigni, SA Stewart | | 2017 |
| Abstract LB-270: Inhibition of the stromal p38MAPK pathway abrogates breast cancer metastases SA Stewart, B Murali, X Su, K Flanagan, J Sponagel, X Luo, Y Fu, ... Cancer Research 76 (14 Supplement), LB-270-LB-270, 2016 | | 2016 |